Ref: Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Section 108 of the Companies Act, 2013 and Rule 20(4) of the Companies (Management and Administration) Rules, 2014 Dear Sir/ Madam, With the reference to the captioned matter, we wish to inform you that in accordance with the order dated 19th December, 2018 of the National Company Law Tribunal Bench at New Delhi, meeting of the equity shareholders of the Company and Secured Creditors & Unsecured Creditors of Artemis Medicare Services Limited (Amalgamated Company No. 2) was convened on Sunday, 27th January, 2019 for approving the composite scheme of amalgamation between Artemis Global Life Sciences Limited, Artemis Health Sciences Limited, Athena Eduspark Limited and Artemis Medicare Services Limited and their respective shareholders and creditors (Composite Scheme). The Equity Shareholders of the Company have duly approved the Composite Scheme with requisite majority, based on Scrutinizer report by way of remote evoting and polling paper. Details of the voting results of the meeting of the Equity Shareholders of the Company along with the copy of the Scrutinizer report are annexed herewith for your reference. Results of evoting along with the Scrutinizers Report are also available on the Companys website: www.aglsl.in. Further, in respect of Artemis Medicare Services Limited: (i) the Unsecured Creditors of Artemis Medicare Services Limited present and voted, have approved the Composite Scheme unanimously in favour of the Composite Scheme. (ii) the Secured Creditors of Artemis Medicare Services Limited present and voted, have approved the Composite Scheme unanimously voted in favour of the Composite Scheme. Submitted for your information and records

Pdf Link: Artemis Global Life Sciences Ltd - Results Of The National Company Law Tribunal (NCLT) Convened Meeting Held On 27Th January, 2019

Source : BSE - www.bseindia.com

comment COMMENT NOW